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Abstract: 
In this study we show how low temperature glow discharge plasma can be used to prepare bi-
layered chromatography adsorbents with non-adsorptive exteriors. The commercial strong 
anion exchange expanded bed chromatography matrix, Q HyperZ, was treated with plasmas in 
one of two general ways. Using a purpose-designed rotating reactor, plasmas were employed 5 
to either: (i) remove anion exchange ligands at or close to the exterior surface of Q HyperZ, 
and replace them with polar oxygen containing functions (‘plasma etching and oxidation’); or 
(ii) bury the same surface exposed ligands beneath thin polymer coatings (‘plasma 
polymerization coating’) using appropriate monomers (vinyl acetate, vinyl pyrrolidone, 
safrole) and argon as the carrier gas. X-ray photoelectron spectroscopy analysis (first ~10 nm 10 
depth) of Q HyperZ before and after the various plasma treatments confirmed that substantial 
changes to the elemental composition of Q HyperZ’s exterior had been inflicted in all cases. 
The atomic percent changes in carbon, nitrogen, oxygen, yttrium and zirconium observed 
after being exposed to air plasma etching were entirely consistent with: the removal of 
pendant Q (trimethylammonium) functions; increased exposure of the underlying yttrium-15 
stabilised zirconia shell; and introduction of hydroxyl and carbonyl functions. Following 
plasma polymerization treatments (with all three monomers tested), the increased atomic 
percent levels of carbon and parallel drops in nitrogen, yttrium and zirconium provided clear 
evidence that thin polymer coats had been created at the exteriors of Q HyperZ adsorbent 
particles. No changes in adsorbent size and surface morphology, nor any evidence of plasma-20 
induced damage could be discerned from scanning electron micrographs, light micrographs 
and measurements of particle size distributions following 3 h exposure to air (220 V; 35.8 W 
L-1) or ‘vinyl acetate/argon’ (170 V; 16.5 W L-1) plasmas. Losses in bulk chloride exchange 
capacity before and after exposure to plasmas enabled effective modification depths within 
hydrated Q HyperZ adsorbent particles to be calculated as 0.2 to 1.2 μm, depending on the 25 
conditions applied. The depth of plasma induced alteration was strongly influenced by the 
power input and size of the treated batch, i.e. dropping the power or increasing the batch size 
resulted in reduced plasma penetration and therefore shallower modification. The selectivity 
of ‘surface versus core’ modification imparted to Q HyperZ by the various plasma treatments 
was evaluated in static and dynamic binding studies employing appropriate probes, i.e. 30 
plasmid DNA, sonicated calf thymus DNA and bovine serum albumin. In static binding 
studies performed with adsorbents that had been exposed to plasmas at the 5 g scale (25 g per 
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litre of plasma reactor), the highest ‘surface/core’ modification selectivity was observed for Q 
HyperZ that had been subjected to 3 h of air plasma etching at 220 V (35.8 W L-1). This 
treatment removed ~53% of ‘surface’ DNA binding at the expense of a 9.3% loss in ‘core’ 
protein binding. Even more impressive results were obtained in dynamic expanded bed 
adsorption studies conducted with Q HyperZ adsorbents that had been treated with air (220 V, 5 
3 h) and ‘vinyl acetate/argon’ (170 V, 3 h) plasmas at 10.5 g scale (52.5 g per litre of plasma 
reactor). Following both plasma treatments: the 10% breakthrough capacities of the modified 
Q HyperZ adsorbents towards ‘surface’ binding DNA probes dropped very significantly (30 – 
85%); the DNA induced inter-particle cross-linking and contraction of expanded beds 
observed during application of sonicated DNA on native Q HyperZ was completely 10 
eradicated; but the ‘core’ protein binding performance remained unchanged cf. that of the 
native Q HyperZ starting material.  
 
Keywords: Anti-fouling; Expanded bed adsorption; Ion exchange; Non-adsorptive surfaces; 
Plasma etching / polymerization; Protein and plasmid DNA separation; Size exclusion; 15 
Support cross-linking 
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1. Introduction 
Preparative chromatography has been a fundamental unit operation for the pharmaceutical 
sector for many decades and plays an absolutely pivotal role within biopharmaceutical 
downstream processing [1-3]. Since Peterson and Sobers prepared cellulose based ion 
exchangers for the separation of proteins in the mid 1950s [1], chromatographic packing 5 
materials for preparative protein separation have been continuously improved with respect to 
large scale operation, resolving power, separation efficiency, selectivity, and sorption capacity 
[1-4]. However, though today’s chromatography materials are unquestionably superior to their 
forerunners, in some ways their development has stood still. For example, the basic design 
and expected tasks have changed surprising little over the past 50 years, with most still 10 
performing just a single function. The explosion in new high-level expression systems for the 
production of recombinant proteins has reduced upstream processing costs to the point where 
concentration and purification operations, i.e. downstream processing, now dominates the 
overall manufacturing cost for many protein therapeutics [3-6]. Yet, though this situation 
creates a great incentive to advance more efficient downstream processing technologies and 15 
processes, especially for future products, the reality is that advances in downstream 
processing over the past decade lag far behind those made in upstream processing over the 
same period, and further, that process chromatography is increasingly viewed as a serious 
bottleneck within biopharmaceutical manufacturing [3-6].  
 20 
Among the growing list of challenges facing the development of new improved 
chromatographic materials for existing and future products are: rocketing product titres; 
increasing size and complexity of emerging bio-products; escalating cost of goods and waste 
generation; and increasing competition from alternative techniques/formats. It is difficult to 
envisage effective solutions to these coming from continued incremental improvement of 25 
conventional mono-functional chromatography adsorbent matrices, i.e. materials performing 
just a single function. Conversely, the concept of multi-functional media featuring two or 
more distinct functional regions spatially separated from one another within the same support 
bead, affords attractive solutions, to at least some of these issues, to be envisaged. The present 
study concerns the simplest multi-layered multi-functional support design one can envisage, 30 
namely one featuring just two differently functionalised layers – an inert outer size excluding 
layer and inner ion exchange functionalised core. The benefits of bi-layered size exclusion 
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chromatography – ion exchange chromatography (SEC-IEC) beaded support designs have 
been clearly demonstrated in the context of ‘nanoplex’ purification [7, 8], fluidised bed 
separation of organic acids [9, 10] and expanded bed adsorption of proteins [11, 12]. The 
important findings from these studies, inherent flaws in the methods employed thus far to 
manufacture bi-layered SEC-IEC hybrids, and identification of a simple and effective solution 5 
to the future manufacture of multi-layered multi-functional beaded chromatography matrices, 
are presented immediately below.  
 
Nanoplexes are a rapidly growing and diverse product grouping characterized by large 
physical size, fragility, complex surfaces plus chemical similarity to smaller contaminating 10 
macromolecular components; important examples include non-viral vector components such 
as naked plasmid DNA, viral vectors, mega-molecular vaccines and mega-protein complexes 
[13-15]. Their properties dictate that their efficient large-scale manufacture must follow a 
very different ‘general’ path to that established for therapeutic human proteins of much 
smaller dimensions [13, 16-21]. Current protocols for the purification of plasmid DNA show 15 
heavy reliance on packed bed chromatography – centred on capture by anion exchange (AEC) 
adsorption, followed by polishing of the salt-eluted fraction by size exclusion chromatography 
[16, 17, 19, 21]. Though ion exchange chromatography has found very widespread use for the 
large scale purification of antibiotics and protein-based drugs, its application for commercial 
scale production of plasmid DNA (pDNA) and other nanoplexes is far less attractive [16-20 
19,21].  
 
Recently, it has been demonstrated that much greater productivity could be realised if the SEC 
and AEC operations are ‘passively’ combined in a single chromatographic operation, 
employing a new type of multi-functional chromatography material (known as the lid bead) 25 
[7, 8]. Starting from an SEC matrix with a nucleic acid exclusion limit of 1000 bp, 
Gustavsson and co-workers [7] made a bi-functional restricted access matrix possessing a 
positively charged core (to adsorb large amounts of RNA and protein) and an inert outer layer 
to exclude pDNA from accessing the functionalised bead interior. The creation of the two 
layers within the matrix was achieved in an ingenious multi-step process, which relied on the 30 
use of limiting concentrations of reactants and ‘diffusion/reaction’ balancing in the second 
step. However, despite showing considerable promise, the bi-functional materials produced 
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did not quite live up to expectations. For example, in tests with plasmid-containing cleared 
alkaline lysate feedstocks of high ionic strength, the authors noted that in order to prevent 
pDNA binding, over 30% of the core’s RNA binding capacity had to be sacrificed. Though 
elegant, the methods of manufacture led to three linked problems, namely insufficient control 
over the: (i) thickness and (ii) inertness of the outer size excluding layer; and (iii) boundary 5 
‘definition’ between the different zones within the support. 
 
A SEC-IEC design is equally attractive for expanded bed adsorption (EBA), a type of 
fluidised bed chromatography, originally conceived as a generic solution for combining solid-
liquid separation with initial chromatographic capture and purification [22-24]. Despite rapid 10 
initial successes, the progress of EBA into industry has been slow, and confidence in the 
technique is waning [25, 26]. Perhaps the greatest technical problem affecting EBA is the 
physical cross–linking of neighbouring adsorbent particles by biomass or large colloidal 
molecules (especially nucleic acids) present in crude feedstocks, which leads to gross 
breakdown/collapse of the structure of the expanded bed and consequent loss of 15 
chromatographic performance [18, 25-34]. Attempts to relieve problems of inter-adsorbent 
particle cross-linking in EBA systems by chemically or mechanically conditioning the crude 
feedstock prior to application have been at best only partially successful [26, 32, 33]. This is 
not surprising given that the root of the problem is that the outer surfaces of expanded bed 
adsorbents, like other beaded chromatographic materials, are populated with functional groups 20 
capable of binding both the product of interest and large adsorbent cross-linking contaminants 
present in crude feedstocks. Commercially available EBA adsorbents are direct descendents 
of packed bed chromatography matrices employed for the purification of proteins, and since 
their inception well over a decade ago the design of improved materials has concentrated on 
improving sorption performance with a view to achieving greater bioprocess intensification. 25 
Two general approaches have found favour, i.e. increasing the potential protein loading 
capacity by raising ligand densities to extreme levels (e.g. GE Heathcare’s Xtra Load range of 
STREAMLINE media), and by manufacturing smaller adsorbent beads with increased 
specific weight (e.g. Pall’s HyperZ adsorbents). Rather than help intensify bioprocesses, both 
of these actions have in fact resulted in less robust EBA operation with crude feedstocks for 30 
which the technique was originally intended [25, 32, 33]. Very little effort has been invested 
thus far on redesigning expanded bed supports for ‘problem-free’ use in crude feedstocks. 
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Most relevant reports to date have involved very low molecular target species, not globular 
proteins, and small pored Amberlite anion exchange resins rather than bona fide porous 
expanded bed supports intended for protein sorption. For example, Daniak and co-workers [9] 
covalently attached polyacrylic acid onto the exterior surfaces of an oppositely charged 
Amberlite ion exchange matrix. The polyacrylic acid layer was penetrable by small molecules 5 
such as the target, shikimic acid, but not to proteins, and repelled much larger negatively 
charged yeast cells and cell debris. The authors demonstrated that, unlike the native Amberlite 
anion exchange matrix, fluidised beds of the polyacrylic acid coated ‘cell repelling’ version 
could be successfully employed for direct capture of shikimic acid from industrial 
fermentation liquors. In related work, Daniak et al. [11] electrostatically adsorbed high 10 
molecular weight polyacrylic acid to the exterior of the commercial expanded bed anion 
exchange adsorbent, STREAMLINE DEAE, and employed the resulting matrix to process bi- 
and tri- component mixtures (i.e. ‘BSA + lysozyme’ and ‘BSA + lysozyme + yeast cells’). 
The adsorbed polyacrylic acid coating proved effective in reducing cell adsorption and 
preventing bed collapse, and remained bound over the range of low ionic strengths employed 15 
(20 mM Tris/HCl supplemented with up to 0.2 M NaCl). However, the potential risk of 
adsorbing oppositely charged contaminating species at the adsorbent’s exterior surface under 
mild operating conditions, makes shielding of adsorbent beads with an oppositely charged 
layer an unattractive proposition for the recovery of protein targets by EBA. Support for this 
concern comes from the authors’ own observations that, BSA (pI = 5) eluted from polyacrylic 20 
acid modified STREAMLINE DEAE, but not from native STREAMLINE DEAE, was 
contaminated with lysozyme (pI = 11). In other work from the same laboratories, Amberlite 
anion exchanger beads were shielded with a thin layer of cross-linked agarose (0.2-1% w/v), 
effectively eliminating binding of E. coli, S. cerevisiae and L. casei without compromising 
dynamic binding capacity towards lactic acid under fluidised bed operation [10]. Most 25 
recently, Jahanshahi and co-workers [12] applied similar methods to laminate commercial 
(STREAMLINE DEAE, CM HyperZ) and prototype expanded bed support materials with 2% 
agarose. These authors made similar claims concerning the benefits of their shielded 
adsorbents, namely reduction in fouling/inter-particle cross-linking and improved bed stability 
in a crude particulate containing feedstock (20% w/v yeast homogenate), plus several more, 30 
such as improved washing efficiency, reduced buffer consumption, shorter operating cycle 
times, improved purity and clarity of eluted target proteins.  
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A fundamental problem afflicting the lamination of adsorbents with agarose (or other gel 
forming polymer) described above, is the difficulty in casting sufficiently thin, uniform, 
mechanically robust layers around core particles (especially of heterogeneous size), and the 
resulting implications on bed expansion properties, hydrodynamics, and especially intra-5 
particle mass transfer and dynamic binding capacity. Although Jahanshahi et al. [12] 
employed a more sophisticated three phase emulsification manufacturing process than that 
described by Viloria-Cols and co-workers [10], much thicker agarose coats were cast in their 
work. Layer thickness was greatest on smaller core particles. After laminating with agarose, 
the mean particle diameter of the small dense HyperZ matrix was observed to increase from 10 
80 to 115 m (equivalent to an agarose layer depth of 17.5 m) and the volume of the particle 
effectively tripled (the original core particle constituted just 34% of the laminated particle’s 
volume). Intra-particle mass transfer has been shown to be the main parameter affecting 
dynamic capacity of an EBA adsorbent [35, 36]. Though not addressed by the authors in their 
work, the consequences of such thick shielding layers on mass transfer kinetics and dynamic 15 
capacity of bi-layered supports are patently clear. It should be noted that the same mass 
transfer problems (arising from poor control of the thickness of size excluding layers) can be 
predicted for the ‘lid’ beads described earlier.  
 
The ideal bi-layered SEC-IEC support for application in EBA processes for protein recovery 20 
from tricky feedstocks, or for separation of nanoplexes, should possess ‘non-stick’ exteriors or 
barriers that are freely accessible to smaller components (proteins, RNA), but not larger 
entities, such as long chain nucleic acids, cell debris fragments, nanoplexes, etc., and in order 
not to compromise mass transport and sorption properties, they must also be very thin [25]. 
To date these criteria have not been met. Unlocking the potential of bi-layered multi-25 
functional chromatography materials urgently requires development of new approaches 
capable of operating at the nano-scale with respect to the outermost surface, e.g. to generate 
ultra-thin ligand devoid layers or coatings that bury offending surface groups.  
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Plasma1 irradiation is a widely recognised and established technology for modifying the 
surface properties of materials at the ‘nano-scale’ [37]. The main advantages of plasma 
treatment of surfaces are: (i) low temperature reactions (i.e. at room temperature); (ii) changes 
occur to the chemical structure of the surface in a shallow nano-scale layer without changing 
the bulk properties; (iii) a very wide range of surface modifications are possible; and (iv) low 5 
amounts of toxic by-products are formed during the treatment [38]. To conduct a surface 
modification by plasma, a glow discharge is created in an evacuated vessel refilled by a low 
pressure gas. Then, radio frequency (RF), microwave (MW), alternating current (AC), or 
direct current (DC) is used to energize the gas. Surfaces of objects in the vessel come in 
contact with the plasma and are bombarded by energetic species (e.g. ions, electrons, 10 
radicals), which transfer energy to the surface, causing chemical and physical reactions. For 
example, during an oxygen plasma treatment, the exposed surface is oxidized, and atoms and 
chemical groups existing on the surface will be replaced by hydroxyl and carbonyl groups 
[39-42]. Removing molecular or atomic layers on the surface can also be conducted by using 
plasma etching [38].  15 
 
Plasma technology has also been used widely for coating of surfaces to make them resistant to 
bioadhesion (i.e. anti-biofouling) for a variety of very different applications [43-46]. This has 
been performed by surface graft polymerization coating or polymer deposition in the presence 
of plasma with or without concurrent surface activation by oxygen, nitrogen or ammonia. The 20 
ability to change the characteristics of a given material surface from hydrophobic to 
hydrophilic or vice versa is another important application of plasma technology. The 
modification of chromatography supports using plasma methods is, in contrast to membrane 
materials [43, 47-52], not well documented, and most reports to date have concerned 
fabrication of restricted access packing materials for analytical separations of small molecules 25 
[53, 54].  
 
Against the above, in this paper we have investigated whether plasma can be used to create 
new bi-layered chromatography supports featuring exteriors modified by either etching and 
oxidation or polymerization coating. A purpose-built plasma reactor was employed in this 30 
work, and the chromatographic starting material selected was the strong anion exchange 
                                                 
1Plasma is defined as a partially or wholly ionized medium consisting of electrons, ions and possibly neutrals and 
photons [37]. 
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expanded bed adsorbent, Q HyperZ. The materials generated were characterised using x-ray 
photoelectron spectroscopy, particle sizing, microscopic techniques, chloride exchange assay, 
and binding studies employing plasmid DNA and sonicated calf thymus DNA as probes for 
loss in surface binding, and bovine serum albumin to gauge for reductions in core binding.  
 5 
2. Experimental  
2.1 Materials 
The Q HyperZ anion exchange adsorbent (Table 1, Fig. 1) employed in this work was 
supplied as a gift from Pall Life Sciences (BioSepra SA, Cergy-Saint-Christophe, France), 
and the size exclusion matrix, Sephacryl S-500 HR was obtained from GE Healthcare Life 10 
Sciences (Amersham, United Kingdom). E. coli DH5 harbouring the 4 kbp plasmid pUG6 
[57] was kindly provided by U. Mortensen (Center for Microbial Biotechnology, Technical 
University of Denmark). Qiagen Plasmid Maxi kits for plasmid purification and GelPilot Plus 
DNA ladders were purchased from Qiagen GmbH (Hilden, Germany). The monomers, vinyl 
pyrrolidone (>99%, V3409), vinyl acetate (purum grade, 99.0%, 4604) and safrole (97%, 15 
S94652) used during plasma polymerization (see Fig. 2) were supplied by Sigma-Aldrich 
Chemical Company (Gillingham, UK) as were all other materials including: tryptone (T7293), 
yeast extract (BioChemika, 92144), sodium chloride (S5886) and ampicillin (BioChemika, 
anhydrous, 98%, 10047) used in the cultivation of  E. coli cells; ammonium iron (III) sulphate 
dodecahydrate (SigmaUltra, 99%, F1668) and mercuric thiocyanate (purum 99.0%, 83374) 20 
for the assay of chloride ions; and deoxyribonucleic acid from calf thymus (type I: sodium 
salt, ‘highly polymerized’, Premium, D1501), bovine serum albumin (BSA; fraction V 
powder, 96% pure by electrophoresis, A 9647), Tris(hydroxymethyl)aminomethane 
(crystalline, 99.9%, T1503) and sodium chloride (SigmaUltra, 99.5%, S7653) employed in 
static and dynamic binding studies. MilliQ water was used in all experiments. 25 
 
2.2 Plasma reactor  
A schematic representation of the custom-made plasma reactor used in this study is shown in 
Figure 3. The plasma was created in a rotating cylindrical Pyrex chamber with a rounded end 
(40 mm diameter × 250 mm length), the exterior of which was coated with a copper/nylon 30 
paper to serve as an electrode. The second electrode, fashioned out of a stainless steel bar (7 
mm diameter × 550 mm length), was positioned in the middle of the plasma chamber. The 
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volume inside the electrodes, i.e. the actual plasma volume, was 0.2 L. During treatment, the 
plasma chamber was rotated continuously so as to ensure complete exposure of the exterior 
surfaces of the adsorbents contained within, to the plasma. An electrical field was created 
within the chamber using a 20 kHz AC generator powered by a standard 0 – 240 V vario-
transformer. For surface etching and oxidation, the oxidation gas was administered into the 5 
plasma reactor via valve 2. The set-up for plasma polymerization was slightly more elaborate; 
reservoirs for monomer solution and the carrier gas, argon, were connected to the plasma 
chamber through valves 1, 3, and 4. 
 
2.3 Plasma treatments 10 
2.3.1 Plasma etching and oxidation  
The rotating plasma reactor (Fig. 3) was operated at room temperature. Portions of Q HyperZ 
matrix (5 or 10.5 g powder equivalent to wet settled bed volumes of 2.4 and 5 mL 
respectively) were placed in the chamber before removing the air using a vacuum pump and 
reducing the pressure to below 10 Pa – a prerequisite for low temperature low pressure glow 15 
discharge plasma (an important consequence of reducing the pressure in this way is that any 
residual water contained within the matrix beads is vaporized). Valve 2 administering 
oxidation gas (air in this study) was subsequently opened and the pressure inside the plasma 
chamber was adjusted to 10 Pa. Rotation (20 rpm) of the reactor was then started, the 
electrodes were connected and plasma was sustained by applying an electric potential of 220 20 
V and frequency of 20 MHz. Visible radiation confirmed that plasma was generated. After 2 
or 3 h of treatment (Table 2), the tumbling was stopped, the power was turned off, the 
electrodes were disconnected and gas evacuation was ceased. Valve 2 was then opened to 
allow equilibration to atmospheric pressure, before opening the chamber and recovering the 
treated beads. Between successive batches, equipment components coming into contact with 25 
the plasma and adsorbents were scrupulously cleaned with acetone, ethanol and then MilliQ 
water, before drying with a hairdryer. Directly after plasma treatment, the adsorbents were 
washed on a sintered glass Buchner filter funnel under vacuum with water (40 mL/mL 
adsorbent), 0.1 M NaOH (20 mL/mL), 0.1 M HCl (20 mL/mL), 20% (v/v) ethanol (60 
mL/mL) solutions and again with water (60 mL/mL), before finally resuspending in 50 mM 30 
Tris-HCl, pH 8 (20 mL/mL) overnight before use.  
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2.3.2 Plasma polymerization 
The procedure used was initially the same as that described above in 2.3.1 (i.e. 5 or 10.5 g 
portions of Q HyperZ were added to the plasma chamber before removing the air inside the 
chamber using a vacuum pump to reduce the pressure to below 10 Pa), but was more 
complicated thereafter. Valves 1 and 4 were opened to evacuate air within all connecting 5 
lines. Once the pressure had begun to decrease, valve 3 was opened completely. When the 
pressure once again started decreasing, valve 3 was closed to avoid losing monomer. Then, 
the argon carrier gas flow into the active compound reservoir was initiated, before very slowly 
opening valve 3 to reach the desired pressure of 15 – 20 Pa, and adjusting the carrier gas flow 
rate into the reactor to 0.3 L h-1. Immediately thereafter, reactor rotation (20 rpm) was started, 10 
before igniting the plasma, and maintaining it (100 – 170 V; 20 MHz) for 0.5 – 3 h (Table 2). 
After treatment, the carrier gas flow was terminated, valves 3 and 4 were closed, before 
breaking the vacuum with air, collecting and washing the treated adsorbents as described 
previously (section 2.3.1). 
 15 
2.4 Adsorbent characterisation 
Untreated and selected plasma treated Q HyperZ adsorbents were examined by X-ray 
photoelectron spectroscopy (XPS), scanning electron microscopy (SEM), light microscopy, 
chemical assay for anion exchange capacity, static binding (section 2.6) and behaviour in 
expanded beds during application of BSA, pDNA and sDNA containing feedstocks (section 20 
2.7).  
 
XPS elemental analysis of the outermost ~10 ± 1 nm thick sub-surface region of adsorbents 
was examined on a SAGE HR 100 spectrometer (Specs GmbH, Berlin, Germany) using a 
non-monochromatic MgK X-ray source operated at a power of 275 Watts (11 keV and 25 25 
mA) and take off angle of 90° from the surface plane. The pressure in the analysis chamber 
was always below 1 × 10-7 mbar, and the sample exposure time was kept to a minimum in 
order to prevent x-ray-induced radiation damage. Atomic concentrations of the elements were 
determined from surface spectra acquired at 100 eV pass energy in the range from 0 to 1100 
eV and were calculated by determining the relevant integral peak intensities using a linear 30 
type background. The systematic error is estimated to be in the order of 5-10%.  
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SEM was conducted using a Zeiss DSM-960 scanning electron microscope (Carl Zeiss AG, 
Oberkochen, Germany). Before the SEM imaging, the samples were coated with a thin layer 
of palladium/gold to minimize the charging effect and increase image contrast. Adsorbents 
were also examined using a Nikon Optiphot light microscope (Nikon, Melville, NY, USA) 
fitted with a Kappa CF-8/1 FMC monochrome video camera (Kappa Opto-electronics GmbH, 5 
Gleichen, Germany). Digitized images and particle size distributions were produced with the 
aid of Image-Pro® Plus software (version 4.1 for Windows; Media Cybernetics, Silver 
Spring, MD, USA).  
 
Protein and DNA contents in samples were determined by UV spectrophotometry (280 nm for 10 
protein and 260 nm for DNA) in a Lambda 20 UV-VIS spectrophotometer (PerkinElmer 
Analytical Instruments, Shelton, CT, USA).  
 
Ionic capacity determinations were carried out as described previously [25]. Briefly, this 
involved incubating 0.5 to 2 mL portions of each adsorbent with 50 mL of 2 M NaCl for 1.5 h 15 
to convert them into the quaternary alkyl ammonium salt form, washing with MilliQ water (3 
× 50 mL) on a glass sinter, before resuspending the drained adsorbents with 50 mL of 0.1 M 
NaOH and mixing for 24 h to displace bound Cl- ions. The Cl- contents in 1 mL aliquots of 
the liquid phase were determined by a colorimetric assay involving mercury (II) thiocyanate 
and ammonium iron (III) sulphate [58]. In the assay, the displacement of the thiocyanate ion 20 
from mercury (II) thiocyanate by Cl- in the presence of Fe3+ results in the formation of a 
highly coloured iron (III) thiocyanate complex, and the intensity of its colour (read in a 
spectrophotometer at 460 nm) is proportional to the original Cl- concentration. 
 
2.5 Preparation of DNA containing feedstocks  25 
Calf thymus DNA was dissolved slowly overnight in 50 mM Tris-HCl, pH 8, to yield a 
viscous 2 mg mL-1 solution, before sonicating on ice with an MSE soniprep 150 (MSE 
Scientific Instruments Ltd., Sussex, UK) using four cycles of 3 s duration and at 70% power. 
After centrifugation at 20,000 gav in the SS-34 rotor of a SORVAL RC5C laboratory 
centrifuge for 0.5 h at 4oC, the sonicated DNA (sDNA) feedstock was portioned into sterile 30 
tubes and stored at –20oC. A size range of 0.4 – 10 kbp for this preparation was determined by 
a combination of electrophoresis in horizontal 0.8% (w/v) agarose gels, and size exclusion 
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chromatography using an ÄKTAexplorer™ 100 air system (GE Healthcare Life Sciences, 
Amersham, United Kingdom). This involved applying small samples on a 60 cm bed of 
Sephacryl S-500 HR (contained in a Tricorn 10/600 column, GE Healthcare Life Sciences, 
Amersham, United Kingdom) that had been previously calibrated using DNA markers of 
known molecular size.  5 
 
E. coli cells containing the plasmid pUG6 were grown in a 5 L batch fermenter on Luria 
Bertani (LB) broth (10 g L-1 Tryptone, 5 g L-1 yeast extract, 10 g L-1 NaCl) containing 100 mg 
L-1 ampicillin. The biomass was harvested after ~20 h of cultivation (dry weight ~10 g L-1) by 
centrifugation at 10,000 gav in the SLA 3000 rotor of a SORVAL RC5C centrifuge for 0.5 h at 10 
4oC. The cell paste was then washed by resuspension in 50 mM Tris-HCl, pH 8 buffer, before 
re-centrifuging as before, and storing at 20oC. Plasmid DNA (pDNA) was purified from 
thawed resuspended E. coli cell pastes using a QIAGEN Plasmid Maxi kit as described by the 
manufacturers.   
 15 
2.6 Static binding studies 
Supports (0.1 mL drained matrix equilibrated in 50 mM Tris-HCl, pH 8) were contacted with 
solutions of BSA (16 mg in 5 mL), sDNA (22.5 mg in 2.5 mL) or pDNA (17.5 mg in 2.5 mL) 
made up in 50 mM Tris-HCl, pH 8 buffer, at room temperature (~22C) on an orbital shaker 
(Infors, Basel, Switzerland). After binding (180 s for DNA, 1 h for BSA), supports were 20 
rapidly separated from suspension. The supernatants were then removed and analysed for 
residual protein or DNA contents (section 2.4). 
 
2.7 Expanded bed adsorption (EBA) experiments 
Given the small quantities of plasma-treated Q HyperZ expanded bed adsorbents generated in 25 
this work, all EBA runs were performed in a 1 cm diameter FastLine10 column (UpFront 
Chromatography A/S, Copenhagen, Denmark). The expanded bed column was connected to a 
FPLC system equipped with a P-1 peristaltic pump, flow-through UV-1 detector (254 nm) and 
FRAC-100 fraction collector (GE Healthcare, Uppsala, Sweden). Settled beds (4 – 4.5 mL 
giving heights, H0, of 5.1 – 5.7 cm) of untreated and plasma treated (Et220-3 and pVAc170-3) 30 
Q HyperZ adsorbents were expanded with Milli Q water at a superficial flow rate of 350 cm 
h-1 and washed copiously, before equilibrating with >50 column volumes of 50 mM Tris-HCl, 
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pH 8 supplemented with 0.1 M NaCl at the same fluid velocity, so that the conductivity of the 
exiting liquid reached that of the incoming buffer (11 mS). Under these buffer and flow 
conditions, beds of all three adsorbent materials under test expanded approximately two-fold 
(i.e. H/H0 = 2, where H is the height of the expanded bed). With the adsorbent beds now 
primed for binding the various feedstocks (1 g L-1 BSA, 0.06 g L-1 sDNA or 0.06 g L-1 5 
pDNA) were applied at 350 cm h-1. In all cases loading was continued until the column outlet 
concentration reached at least 25% of the inlet value, and bed heights were periodically 
recorded. The BSA, sDNA and pDNA concentrations in the feedstocks and in collected 
fractions were determined at the end of each experiment by UV absorbance measurements as 
described earlier (section 2.4). 10 
 
3. Results and discussion 
3.1 Selection of Q HyperZ for plasma modification 
The commercial anion exchange expanded bed adsorbent, Q HyperZ was selected for surface 
plasma modification for three main reasons, i.e. its unique ‘gel-in-a-shell’ architecture; 15 
availability in powder form with low water content (Table 1); and high binding capacity 
towards pDNA and sDNA cf. other beaded adsorbents.  
 
Q HyperZ is a composite beaded material (Fig. 1) of high mechanical strength comprising a 
porous rigid skeleton of yttrium-stabilized zirconium oxide, which is completely filled and 20 
coated with a soft flexible functionalized hydrogel – synthesized by polymerizing the 
functional monomer, methacryloylaminopropyl trimethylammonium, together with the bi-
functional cross-linking monomer, N, N'-methylene bisacrylamide [56, 59]. During 
manufacture, the monomers and co-monomers are dissolved in an appropriate solvent and 
introduced into the bead in liquid form. Polymerization is then initiated to produce rigid 25 
beads, whose pores are filled with a cross-linked functionalised poly(acrylamide) gel. The 
volume of monomer solution is calculated so that in addition to completely filling the pores, 
the exterior surface is covered with a thin layer of gel (E. Boschetti, personal communication). 
Using confocal microscopy we have observed that this layer is of variable depth (data not 
shown). The thickness on most beads lies between 1 and 2 m, but regions with much thinner 30 
coverage or no apparent cover, i.e. bare patches of shell, were also observed. 
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Q HyperZ comes as a white powder with very low water content (<5% w/w; 1% for lot VC 
220801). Thus we argued Q HyperZ might be able to withstand effects of dehydration in the 
low pressure atmosphere of the plasma reactor and potential abrasion during tumbling, much 
better than other beaded chromatography media, i.e. cross-linked polymeric matrices with 
high water contents.  5 
 
Compared to other expanded bed matrices, Q HyperZ (and its packed bed equivalent Q 
HyperD) exhibits relatively high binding capacities towards pDNA and sDNA [18, 34]. 
Plasmids are as large as or larger than the pores of most beaded chromatography materials and 
thus any binding that occurs is strictly limited to the exterior surface [16, 18, 60]. Two 10 
architectural features of Hyper media are likely to be responsible for elevated pDNA and 
sDNA binding [18]. First, unlike most porous media the entire exterior surface of Hyper 
adsorbents is available for adsorption, and second, the thin layer of functionalised gel 
covering the surface (see Fig. 1) is highly folded [2]. 
 15 
3.2 Strategies applied for plasma treatment  
Two strategies were employed to provide adsorbents devoid of (or depleted in) anion 
exchange functions at the exterior surface (Fig. 1), i.e.: plasma was used to either: (i) ‘shave’ 
away only those cationic ligands located at or close to the exterior surface (surface etching 
and oxidation) and replace them with polar oxygen containing ones, e.g. hydroxyls, carbonyls, 20 
carboxyls [38-45, 61, 62], or (ii) bury the surface exposed ligands of the native Q HyperZ 
adsorbent beneath a thin polymer blanket layer via plasma polymerization. The argon plasma 
creates radicals in the substrate’s surface able to react with vinyl or acrylic monomers or 
radicals created in the plasma. Some etching will occur here also, but to a lesser extent given 
the reduced power employed. The plasma treatments explored in this work are presented in 25 
Table 2. Two of the monomers (Fig. 2) – vinyl acetate and vinyl pyrrolidone – were chosen 
for the antifouling characteristics that the resulting polymers – poly(vinyl acetate) and 
especially poly(vinyl pyrrolidone) – impart to surfaces [47-52, 63, 64], and the third (safrole) 
was used because previous work had shown this hydrophobic polycyclic compound 
polymerized very efficiently from gas plasma [65]. The power and treatment times employed 30 
were selected based on previous experience with plasma modification of other substrates, and 
some preliminary screening tests.  
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3.3 Elemental analysis of adsorbent surfaces using XPS 
We employed XPS to analyse the elemental composition of the first 10 ± 1 nm depth of the 
exterior surfaces of Q HyperZ before and after exposure to various plasma treatments. 
Examination of the XPS data following treatment of 5 g batches of Q Hyper Z (Table 2) 5 
confirms that all plasma modifications applied changed the elemental composition of Q 
HyperZ’s surface. The various modified adsorbents are identified in abbreviated form by the 
treatments they received. Thus, an adsorbent that had been air plasma etched at 220 V for 2 h 
is identified by ‘Et220-2’, whereas one plasma polymerized with poly(vinyl acetate) at 170V 
for 3 h is denoted by ‘pVAc170-3’, etc.  10 
 
The detection of Zr and Y at the surfaces of unmodified Q HyperZ is consistent with the 
confocal microscopic detection of thin surface gel and bare patches of exposed yttrium 
stabilised zirconia shell mentioned earlier (section 3.1). The reduction in atomic percent 
values (at. %) of carbon and nitrogen to undetectable levels and parallel rises in at. % levels of 15 
oxygen, zirconium, and yttrium, following air plasma etching (see Et220-2 and Et220-3 cf. 
untreated Q HyperZ), are entirely consistent with: (i) the removal of pendant trimethyl 
ammonium functional groups (or molecular layers of the Q-functionalised gel itself) from Q 
HyperZ; (ii) consequent increased exposure of the underlying shell; and (iii) surface 
oxidation, i.e. introduction of hydroxyl and carbonyl functions [38-45, 61, 62]. An increase in 20 
treatment time from 2 to 3 h exerted little impact on the elemental composition of the surface. 
 
Following deposition of the plasma polymer coating on Q HyperZ the at. % values for carbon 
increased, while those for zirconium and yttrium dropped. These changes were noted in all 
cases (regardless of monomer, power, time employed) providing strong evidence that 25 
polymerization coating had occurred at the adsorbent exterior. For plasma polymerization 
reactions with vinyl acetate, increasing the treatment time from 2 to 3 h was accompanied by 
an increase in at. % C, and significant reductions in at. % N, Zr and Y, implying that the 
polymer layer deposited on pVAc170-3 was deeper than that on pVAc170-2. 
 30 
XPS analysis implies that plasma polymerization of vinyl acetate onto Q HyperZ under 
plasma was less efficient than with safrole or vinyl pyrrolidone. For example, treatment of Q 
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HyperZ with a ‘vinyl acetate - 170 V - 3h’ plasma yielded significantly higher at. % N, Zr and 
Y contents cf. Q HyperZ that had been exposed to a ‘safrole -130 V- 0.5 h’ plasma treatment. 
  
In contrast to other plasma treatments, i.e. air etching, or coating with poly(safrole) or 
poly(vinyl acetate), the at. % N determined by XPS doubled following plasma modification 5 
with poly(vinyl pyrrolidone), i.e. from 5.1% to 10.0% for pVP100-1 and 11.6% for pVP140-
1. The elevated at. % N contents of these two materials reflect the higher nitrogen content of 
the vinyl pyrrolidone monomer (Fig. 2) cf. that of the substrate Q HyperZ, and provides firm 
evidence that surface modification with poly(vinyl pyrrolidone) had been occurred. Increasing 
the voltage during plasma deposition of poly(vinyl pyrrolidone), from 100 to 140 V, was 10 
accompanied by very substantial drops in atomic percentages of Zr and Y at the adsorbent 
exterior, commensurate with a thicker coating due to a higher deposition rate.  
 
Though significant drops in Zr and Y were detected for all polymer-coated Q HyperZ 
samples, their complete eradication from XPS analyses was not observed. This implies that 15 
the applied coatings: (i) were substantially less than 10 nm thick; and/or (ii) may not cover the 
entire outer support surface, leaving bare or thinly covered patches of yttrium-stabilised 
zirconia shell.  
 
3.4 Selectivity of ‘surface versus core’ modification of various plasma treatments 20 
The effects of the various plasma treatments on the selectivity of ‘surface’ over ‘core’ 
modification of Q HyperZ was evaluated in simple batch binding tests, conducted with sDNA 
(0.4 – 10 kbp) or pDNA as probes for loss in surface binding and BSA to gauge for reduction 
in core binding. Q HyperZ is a composite chromatographic support that uses hyper-diffusion 
(also known as surface or solid diffusion) to enhance mass transfer of proteins and other small 25 
molecules, i.e. adsorbed proteins move within the functionalised gel [2]. However, it is clear 
that, in common with other more conventional porous beaded chromatography supports, the 
binding of pDNA and large sDNA fragments to Hyper media (e.g. Q HyperZ and Q HyperD) 
is confined to their exterior surface [16-18, 34, 60, 66-68] and occurs within a much shorter 
timescale than protein sorption [31, 34, 67, 68]. Figure 4a shows loss in surface DNA binding 30 
of the plasma treated supports listed in Table 2 plotted as a function of their loss in core BSA 
binding, and Figure 4b summarises the relative success of the different plasma treatments in 
19 
 
terms of a selectivity index, calculated simply by dividing the % retained core BSA binding 
by the % retained surface DNA binding – the higher the number the better the support.  
Surface etching and oxidation produced the greatest reduction in surface sDNA and pDNA 
binding (Fig. 4a) and also the highest selectivity index, i.e. 2.0 for Et220-3 (Fig. 4b). For 
example, Et220-3 possessed less than half of the sDNA and pDNA binding capacity of 5 
untreated Q HyperZ (Fig. 4a) whilst retaining a high level of core BSA binding (i.e. >90%). 
 
XPS analysis of Et220-3 (Table 2) indicated that sufficient Q-functionalized polyacrylamide 
gel had been removed to expose the underlying zirconium oxide shell. The protein sorption 
characteristics of zirconium oxide are complex. Voute and co-workers [59] showed that bare 10 
zirconium oxide is unable to bind cytochrome c (pI = 10.2) at any pH between 4.5 and 8.6, 
indicating that its surface is cationic, and that BSA (pI = 5.1) adsorbed non-selectively on 
zirconia via non-ionic interactions. Further, the sorption behaviour of naked zirconia is highly 
dependent on the buffer system employed. For example, following prior incubation with a 
strong Lewis base (e.g. 0.5 M phosphate) the zirconia surface was able to acquire anionic 15 
character, because Lewis acid sites on the surface bound Lewis bases from solution to 
generate a negative charged exterior [59, 69]. Despite all of the above the contributions of 
exposed zirconia shell to the BSA binding properties of Et220-3 are likely to be negligible. 
This is because an extremely low percentage of shell surface is likely to be available for 
binding; the surface area of the empty porous yttrium-stabilised zirconia shell used in the 20 
construction of Q HyperZ is just 1 m2/g.  
 
A relatively high selectivity index (1.49) was also observed for the poly(safrole) treated Q 
HyperZ. However, unlike all other plasma treated supports this material was deemed 
unsuitable for EBA given its propensity to agglomerate strongly in aqueous solutions – an 25 
observation consistent with safrole’s polycyclic ring structure (see Fig. 2). The poly(vinyl 
acetate) coated adsorbents displayed comparatively modest selectivity indices (1.13 – 1.37, 
Fig. 4b); but the best reduction in sDNA binding capacity exhibited by a plasma polymer 
modified Q HyperZ was shown by pVAc170-3 (Fig. 4a). The BSA and sDNA binding 
characteristics of poly(vinyl pyrrolidone) modified adsorbents were quite different to those of 30 
other plasma treated Q HyperZ supports. These polymer coated materials were characterised 
by selectivity indices less than unity (Fig 4b). Poly(vinyl pyrrolidone) is widely recognized as 
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a potentially important surface modification agent for biomedical and bioprocessing 
applications, given its excellent biocompatibility with living tissues and extremely low 
cytotoxicity [70], and that it prevents cell adhesion, inhibits binding of platelets [52] and 
plasma proteins [51, 52, 63], increases surface wettability and reduces adsorptive fouling [48-
50]. Numerous studies conducted with model proteins, including BSA, confirm that 5 
modification of a given support material with poly(vinyl pyrrolidone) significantly reduces 
protein adsorption. In contrast, reports on nucleic acid binding to poly(vinyl pyrrolidone) or 
poly(vinyl acetate) modified materials could not be found. The inverted ‘surface/core’ 
selectivity behaviour noted for poly(vinyl pyrrolidone) coated Q HyperZ cf. all other plasma 
modified adsorbents in this study (i.e. greater reduction to core BSA than to surface sDNA 10 
binding) provides evidence that nucleic acid adsorption is less strongly affected by poly(vinyl 
pyrrolidone). 
 
For surface etched Q HyperZ the most obvious cause of loss in core BSA binding is removal 
of ion exchange ligands from the outermost surface of the matrix. In order to establish how far 15 
into the support plasma etching had extended, we made careful measurements of the ionic 
capacity of Q HyperZ before and after the air plasma etching treatment. The original chloride 
exchange capacity, of 131.4 mmol mL-1 (Table 1) for Q HyperZ, fell following 3 h exposure 
to air plasma to 118.3 mmol mL-1 (Table 3). This 10.0% drop in ionic capacity almost exactly 
mirrored the loss in core BSA binding (9.3%, Fig. 4a). Assuming an average bead diameter of 20 
70 m (Table 1), and two further oversimplified assumptions, i.e. uniform distribution of 
ligand throughout the support, and an absolute distinction between etched and non-etched 
regions, a 10% loss in Cl- exchange capacity (or BSA binding) translates to a mean ‘effective’ 
modification depth within the hydrated particle of 1.2 m. In truth, the situation is a good deal 
more complex than this, given that: (i) the method of manufacture of Q HyperZ results in 25 
sorbent beads encased in a thin layer of functionalised gel (section 3.1); thus the distribution 
of ligand within a Q HyperZ bead is not uniform – it is slightly more concentrated at the bead 
surface; and (ii) formation of a clear-cut boundary, separating modified and unmodified 
regions, is unlikely.  
 30 
The rigid porous zirconia skeleton of Q HyperZ prevents swelling of the 3-dimensional 
polymerized cationic hydrogel locked inside [2]. The thin surface gel-layer however, is not 
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subject to the same physical constraints, and is therefore able to swell significantly (from the 
initial polymerized or dry state) on immersion in aqueous solvents. Plasma etching was 
performed when the adsorbent was in the form of a dry powder, thus the actual depth of 
penetration achieved during the plasma treatment is likely to be much less than the 1.2 m 
estimate for a hydrated 70 m Q HyperZ particle. Under these conditions, the gel-layer 5 
coating the adsorbent’s exterior will be in a dehydrated and therefore collapsed state, i.e. it 
will be very much thinner. In water the swollen state of the cationic hydrogel used to fill Q 
HyperZ is >14 times that of the original polymerized constrained state2; this is largely due to 
repulsion between like charges along the polymer backbone [2]. The depth of the dry 
collapsed gel-layer will be much smaller again than the original constrained state. Thus, a 10 
more realistic estimate of the air plasma etching penetration depth into Q HyperZ is of the 
order of 20 nm or more, and is certainly greater than the maximum XPS analysis depth of 10 
nm. 
 
The significant losses in core BSA binding for polymer coated supports are more complex to 15 
explain. Here again, reductions in ionic capacity were observed, but were too small to fully 
account for the loss in core BSA binding determined (e.g. for pVAc170-3 the reduction in Cl- 
exchange capacity and BSA binding were 4.4% (Table 3) and 17 % (Fig. 4a) respectively. 
The ‘additional loss’ in protein binding as a consequence of polymer coating at and beneath 
the immediate exterior surface, i.e. in a sub-surface region (ca. 0.5 μm for pVAc170-3; Table 20 
3), can be assigned to steric and mass transfer related effects.  
 
Just two of the original seven plasma treatments in Table 2 were selected for further study, i.e. 
‘surface etching at 220 V for 3 h’ and ‘surface coating with poly(vinyl acetate) at 170 V for 3 
h’. Multiple batches of identically prepared Et220-3 and pVAc70-3 were pooled to provide 25 
sufficient of each matrix for SEM, light microscopy/particle sizing, ionic capacity 
determinations and three parallel expanded bed runs (using 4 – 4.5 mL settled beds in Fastline 
10 contactors) with BSA, sDNA and pDNA containing feedstocks. Table 3 illustrates the 
impact of treated batch size on surface XPS and core ionic capacities of Q HyperZ following 
                                                 
2 Prior and during polymerization of the cationic gel filling the HyperZ skeleton electrostatic repulsion between 
the positively charged monomers is heavily suppressed using appropriate salts and solvents. After 
polymerization, and when charge shielding is lifted, the hydrogel, if unconstrained, expands dramatically as like 
charges repel one another strongly [2]. 
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plasma etching and plasma polymerization coating with poly(vinyl acetate). An approximate 
doubling in batch size from 5 to 10.5 g exerted relatively little impact on the elemental 
compositions of the first ca. 10 nm of Et220-3 and pVAc170-3 supports, but essentially 
halved the loss in ionic capacity (from 10 to 4.2% for Et220-3 and from 4.4 to 2.0% for 
pVAc170-30. As the support mass (and therefore exterior surface) treated per litre of plasma 5 
is doubled (i.e. from 25 to 52.5 g L-1) the effective numbers of active species in the plasma 
bombarding a given patch of support surface are effectively halved, and thus the extent and 
‘effective’ depth of modification is significantly reduced (i.e. from 1.2 to 0.5 m for Et220-3 
and from 0.5 to 0.2 m for pVAc170-3).  
 10 
3.5 Impact of plasma treatment on the appearance and size of Q HyperZ  
Scanning electron microscopy at 1000- and 10,000- fold magnifications was unable to reveal 
discernible differences (down to the ca. 0.2 μm level) in size or surface morphology of Et220-
3, pVAc170-3 and untreated Q HyperZ beads following plasma modification at the 10.5 g 
scale (Fig. 5). No changes in the appearance of Q HyperZ before and after plasma treatment 15 
could be seen under light microscopy – the particle size distributions (Fig. 6a-c) and mean 
particle diameters (73.3, 72.2 and 73.2 m for untreated Q HyperZ, Et220-3 and pVAc170-3 
respectively) were strikingly similar – and nor was there any evidence for plasma induced 
damage, such as e.g. increased generation of fines, presence of fragmented supports and/or 
changes in bead shape.  20 
 
3. 6 Expanded bed adsorption (EBA) studies 
XPS surface analysis (Tables 2 & 3) confirmed that all plasma treatments inflicted significant 
changes to the surface of Q HyperZ, and that increasing the batch size reduced ligand loss in 
predictable fashion (Table 3). The extent to which air plasma etching and plasma polymer 25 
coating (conducted using 52.5 g of Q HyperZ per L of plasma) affected the ability of the 
resulting adsorbents to bind pDNA, sDNA and BSA in expanded beds is presented in Fig.7. 
At the operating flow rate of 350 cm h-1 (initial expansion H/H0 = 2; initial voidage, i= 0.7) 
in a 50 mM Tris-HCl pH 8 buffer containing 0.1 M NaCl the dynamic binding capacities at 
10% breakthrough (DBC10%) of untreated Q HyperZ for pDNA, sDNA and BSA were 1.5 30 
(Fig. 7a), 6.9 (Fig. 7b) and 33.5 (Fig. 7c) mg mL-1 respectively. Following poly(vinyl acetate) 
deposition (pVAc170-3) the pDNA DBC10% dropped by nearly 30% to 1.1 mg mL-1 (Fig. 7a) 
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and an even greater reduction in dynamic pDNA binding of 50% (0.75 mg mL-1) was 
observed for the air plasma etched ‘Et220-3’ Q HyperZ (Fig. 7a). Even greater reductions in 
DBC10% following plasma treatment were found when sDNA was employed as a probe for 
surface binding. The air plasma etching treatment wiped out nearly 85% of the DBC for 
sDNA (a drop from 7 to <1.3 mg mL-1, Fig. 7b), and although pVAc coating proved less 5 
effective, it nevertheless reduced dynamic sDNA binding by nearly 65% (Fig. 7b). The 
significant reductions in DBC10% of ‘surface’ binding probes, pDNA and sDNA, observed 
following both plasma treatment of Q HyperZ (Figs 7a and b respectively) are in striking 
contrast to the almost complete absence of a loss in  both ‘core’ BSA binding (Fig. 7c) and 
ion exchange capacity (Table 3) for the same adsorbent materials (i.e. DBC10% values of 33.5, 10 
32.8 & 34.8 mg mL-1, and Cl- exchange capacities of 131.4, 125.9 & 128.8 mmol L-1 – for 
untreated, Et220-3 and pVAc170-3 supports respectively).  
 
A common feature during the application of sDNA containing liquors onto expanded beds of 
anion exchange adsorbents is, to varying degrees depending on the particular support and 15 
prevailing ionic strength, the progressive contraction of the bed caused by sDNA molecules 
pulling or flocculating neighbouring adsorbent particles together resulting in aggregated and 
physically cross-linked fluidised beds [18, 25, 31, 34]. In these experiments the suspending 
buffer (50 mM Tris/HCl pH 7.5) was supplemented with 0.1 M NaCl; the reason being that 
previous work with expanded beds of Q HyperZ and sDNA feedstocks showed that this action 20 
eliminated flow channelling within the expanded bed, without influencing bed contraction 
behaviour. Scrutiny of bed contraction profiles during the application of BSA (Fig. 7c), 
pDNA (Fig. 7a) and sDNA (Fig. 7b) on two-fold expanded beds of unmodified and plasma 
treated Q HyperZ confirmed that: (i) bed contraction only occurred when the feedstock 
contained sDNA; and (ii) severe bed contraction was only observed for the unmodified Q 25 
HyperZ. In this case, the bed progressively contracted reaching a minimum voidage ( = 0.62; 
H/H0 <1.6) after applying 5 mg sDNA/mL support, before gradually re-expanding as further 
sDNA feedstock was supplied to the bed. Clearly, both plasma treatments were effective in 
reducing the extent of DNA induced bed contraction (Fig. 7b). Taken collectively, the bed 
contraction and dynamic binding data presented here supports the assertion that the low 30 
temperature low pressure plasma etching and coating methods we have applied can be used to 
effectively modify the surface of adsorbents without significantly compromising the binding 
24 
 
properties of the core. It is reasonable to assume that the plasma treatments identified here as 
effective solutions for dealing with expanded bed adsorptive separations from problematic 
nucleic acid containing feedstocks, should also be applicable to EBA from other troublesome 
feedstocks, such as those containing whole or disrupted cells, as well as to packed bed 
chromatographic separation of nanoplex species from smaller chemically similar 5 
contaminants.  
 
4. Conclusions 
Low temperature plasma discharge treatment is an effective means of conducting nano-scale 
surface modifications to beaded chromatography adsorbents. Ligands can be shaved off the 10 
surface of adsorbents via plasma etching and oxidation, or coated with a nano-thin polymer 
layer by plasma polymerization. The plasma treatments are gentle and physical damage to the 
adsorbents was not observed. Plasma modification of Q HyperZ supports resulted in 
adsorbents with (i) substantially reduced surface charge, (ii) much lower binding capacity 
towards large DNA molecules and (iii) reduced sensitivity to sDNA induced bed contraction, 15 
and (iv) without compromising mass transfer and binding of BSA to the interior 
functionalised core of the supports. In general, the results found in this work suggest that 
removing surface ligands by air plasma etching was more successful than covering them via 
plasma polymerization. However, as only three monomers were applied in this study, it is 
entirely possible that the use of others could make plasma polymerization an equally attractive 20 
or better option than etching.  
 
The procedures described in this work have been applied to commercially available 
adsorbents. The generation of large quantities of bi-layered supports from such starting 
materials using plasma technology should be relatively straightforward. No complicated re-25 
design or engineering of the manufacturing process is required, and plasma treatment for the 
similar applications, e.g. preparation of dispersible polyolefin powders (diameter 20 – 120 
µm) by oxygen plasma, is already conducted at large scale using reactors of ~ 120 L volume 
[71,72]. Plasma modification could thus be an ‘add on’ treatment to already established 
packed bed and EBA chromatography adsorbent manufacturing processes.  30 
 
25 
 
Careful optimization of plasma treatment parameters has not been the focus of this work, but 
is clearly a prerequisite prior to establishing robust methods for large scale preparation of bi-
layered chromatographic supports with non-adsorptive surfaces. Finally, the extension of low 
temperature low pressure plasma treatments disclosed here for Q HyperZ, to other beaded 
chromatographic support materials, and selection of alternative coatings tailored to specific 5 
functions (i.e. other neutral hydrophilic, functionalised or even smart polymers with 
switchable behaviour), should be done in order to assess whether plasma methods have a role 
to play in the future provision of multi-functional chromatography materials for the 
bioprocess industries.  
 10 
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Figure captions 
Fig. 1. Strategies applied for plasma surface modification of Q HyperZ adsorbent beads. Here 
‘+’ represents the quaternary amine ligand distributed on the surface and throughout the 
adsorbent. 
 
Fig. 2. Monomers employed for low temperature/low pressure plasma polymerization coating 
of Q HyperZ.  
 
Fig. 3. Rotating low temperature low pressure reactor set-up for plasma etching and oxidation 
and plasma polymerization coating. 
 
Fig. 4. (a) Reduction in surface DNA binding vs. reduction in core BSA binding and (b) the 
resulting ‘surface vs. core’ selectivity indices for the plasma treated Q HyperZ adsorbents 
listed in Table 2 (5 g scale). Key: sDNA (up-triangles); pDNA (down-triangles); plasma 
polymerized (black bars); and plasma etched (white bars) Q HyperZ. The BSA, sDNA and 
pDNA binding capacities of untreated Q HyperZ in 50 mM Tris-HCl, pH 8 were respectively 
70.6, 4.4 and 3.1 mg per mL adsorbent. 
 
Fig. 5. SEM images of (a) untreated, (b) plasma etched ‘Et220-3’, and (c) plasma polymerized 
‘pVAc170-3’ Q HyperZ adsorbents (Table 3, 10.5 g scale) at 1000 × (top) and 10,000 × 
(bottom) magnification. The white size bars represent 10 and 1 m for the low and high 
magnification fields respectively. 
 
Fig. 6. Particle size distributions and light microscopy images (inserts) of (a) untreated, (b) 
plasma etched ‘Et220-3’, and (c) plasma polymerized ‘pVAc170-3’ Q HyperZ adsorbents 
(Table 3, 10.5 g scale). Mean particle sizes of 73.3, 72.2 and 73.2 m were determined for the 
untreated, Et220-3 and pVAc170-3 adsorbent preparations respectively. 
 
Fig. 7. Breakthrough curves and bed contraction profiles during the binding of  (a) pDNA, (b) 
sDNA and (c) BSA to expanded beds of untreated, plasma etched ‘Et220-3’, and plasma 
polymerized ‘pVAc170-3’ Q HyperZ adsorbents (Table 3, 10.5 g scale). Key: Untreated 
(filled grey symbols), ‘Et220-3’ (open symbols) and ‘pVAc170-3’ (filled black symbols) Q 
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HyperZ adsorbents; pDNA (,,); sDNA (,,); BSA (,,); and bed voidage,  
(,,). Bed voidage was calculated employing assuming a value of 0.4 for the settled bed 
[55].  
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